Abstract：
BACKGROUND: Adequate postoperative pain treatment is important for quality of life, patient satisfaction, rehabilitation, function, and total opioid consumption, and might lower both the risk of chronic postoperative pain and the costs for society. Prolonged opioid consumption is a well-known risk factor for addiction. Previous studies in upper extremity surgery have shown that total opioid consumption is a third of the amount prescribed, which can be explained by package size. The aim of this study was to examine whether implementation of prepacked takehome analgesia bags reduced the quantity of prescribed and dispensed opioids.
METHODS: We introduced prepacked take-home analgesia bags for postoperative pain treatment in outpatient surgery. The bags came in two sizes, each containing paracetamol, etoricoxib, and oxycodone. The first 147 patients who received the prepacked analgesia bags were included in the study, and received a questionnaire one month after surgery covering self-assessed pain (visual analog scale of 0-10) and satisfaction (0-5), as well as opioid consumption. Prescription data after introducing the analgesia bags were compared with data before the bags were introduced.
RESULTS: Of the 147 patients included in the study, 58 responded. Compared to standard prescription (small bag group: 14 oxycodone immediate release capsules (5 mg), large bag group: additional 28 oxycodone extended release tablets (5 mg), based on the smallest available package), the patients in the small analgesia bag group received 50% less oxycodone and 67% less for the large bag group. Patients with small bags consumed a median of 0.0 mg oxycodone and those with large bags consumed a median of 25.0 mg oxycodone. The median satisfaction was 5.0 (range: 2-5) and the median pain score was acceptable at the first postoperative day. Prescription data showed a significant reduction of 60.0% in the total amount of prescribed opioids after the introduction of prepacked analgesia bags.
CONCLUSIONS: The introduction of prepacked analgesia bags dramatically reduced the quantity of opioids prescribed after outpatient hand surgery. Patient satisfaction was high and the postoperative pain level was acceptable.
BACKGROUND: analgesia, hand surgery, opioids, outpatint surgery, wrist surgery.
METHODS: We introduced prepacked take-home analgesia bags for postoperative pain treatment in outpatient surgery. The bags came in two sizes, each containing paracetamol, etoricoxib, and oxycodone. The first 147 patients who received the prepacked analgesia bags were included in the study, and received a questionnaire one month after surgery covering self-assessed pain (visual analog scale of 0-10) and satisfaction (0-5), as well as opioid consumption. Prescription data after introducing the analgesia bags were compared with data before the bags were introduced.
RESULTS: Of the 147 patients included in the study, 58 responded. Compared to standard prescription (small bag group: 14 oxycodone immediate release capsules (5 mg), large bag group: additional 28 oxycodone extended release tablets (5 mg), based on the smallest available package), the patients in the small analgesia bag group received 50% less oxycodone and 67% less for the large bag group. Patients with small bags consumed a median of 0.0 mg oxycodone and those with large bags consumed a median of 25.0 mg oxycodone. The median satisfaction was 5.0 (range: 2-5) and the median pain score was acceptable at the first postoperative day. Prescription data showed a significant reduction of 60.0% in the total amount of prescribed opioids after the introduction of prepacked analgesia bags.
CONCLUSIONS: The introduction of prepacked analgesia bags dramatically reduced the quantity of opioids prescribed after outpatient hand surgery. Patient satisfaction was high and the postoperative pain level was acceptable.
BACKGROUND: analgesia, hand surgery, opioids, outpatint surgery, wrist surgery.
摘要：
背景：适当的术后疼痛治疗对生活质量很重要，患者满意度,康复,函数,和阿片类药物的总消费量，并可能降低慢性术后疼痛的风险和社会成本。长期服用阿片类药物是众所周知的成瘾风险因素。先前在上肢手术中的研究表明，阿片类药物的总消费量是处方量的三分之一，这可以用包装尺寸来解释。这项研究的目的是检查预包装的外卖镇痛袋的实施是否减少了处方和分配的阿片类药物的数量。
方法：我们介绍了用于门诊手术术后疼痛治疗的预包装家用镇痛袋。袋子有两种尺寸，每个都含有扑热息痛，依托考昔,和羟考酮.前147名接受预包装镇痛袋的患者被纳入研究，并在手术后一个月收到一份涵盖自我评估疼痛（视觉模拟量表0-10）和满意度（0-5）的问卷，以及阿片类药物的消费。将引入镇痛袋后的处方数据与引入袋之前的数据进行比较。
结果：在纳入研究的147名患者中，58回答与标准处方相比（小袋组：14个羟考酮速释胶囊（5毫克），大袋组：额外的28羟考酮缓释片（5毫克），基于最小的可用包)，小镇痛袋组患者接受的羟考酮减少50%,大镇痛袋组患者接受的羟考酮减少67%.小袋患者消耗的羟考酮中位数为0.0mg，大袋患者消耗的羟考酮中位数为25.0mg。中位满意度为5.0（范围：2-5），中位疼痛评分在术后第一天可接受。处方数据显示，在引入预包装的镇痛袋后，处方阿片类药物的总量显着减少了60.0％。
结论：采用预包装的镇痛袋可显著减少门诊手手术后处方阿片类药物的用量。患者满意度高，术后疼痛程度可接受。
背景：镇痛，手外科,阿片类药物,Outpatint手术,手腕手术.
方法：我们介绍了用于门诊手术术后疼痛治疗的预包装家用镇痛袋。袋子有两种尺寸，每个都含有扑热息痛，依托考昔,和羟考酮.前147名接受预包装镇痛袋的患者被纳入研究，并在手术后一个月收到一份涵盖自我评估疼痛（视觉模拟量表0-10）和满意度（0-5）的问卷，以及阿片类药物的消费。将引入镇痛袋后的处方数据与引入袋之前的数据进行比较。
结果：在纳入研究的147名患者中，58回答与标准处方相比（小袋组：14个羟考酮速释胶囊（5毫克），大袋组：额外的28羟考酮缓释片（5毫克），基于最小的可用包)，小镇痛袋组患者接受的羟考酮减少50%,大镇痛袋组患者接受的羟考酮减少67%.小袋患者消耗的羟考酮中位数为0.0mg，大袋患者消耗的羟考酮中位数为25.0mg。中位满意度为5.0（范围：2-5），中位疼痛评分在术后第一天可接受。处方数据显示，在引入预包装的镇痛袋后，处方阿片类药物的总量显着减少了60.0％。
结论：采用预包装的镇痛袋可显著减少门诊手手术后处方阿片类药物的用量。患者满意度高，术后疼痛程度可接受。
背景：镇痛，手外科,阿片类药物,Outpatint手术,手腕手术.
